Anti-herpesvirus therapies:
Basic strategies and applications

Chaire Francqui - 13 février 2003 

Click here to start


Table of Contents

PPT Slide

Herpesviridae Human herpesviruses (HHV)

PPT Slide

PPT Slide

PPT Slide

Antiviral activity spectrum of valaciclovir (acyclovir)

Major clinical indications of valaciclovir

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

Comparative potency of different antiherpetic compounds against different herpesviruses

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

Major clinical indications of BVDU (Brivudin)

Oral brivudin versus intravenous acyclovir in the treatment of severe herpes zoster in cancer patients

PPT Slide

Current antiviral therapy for zoster

Brivudin compared to acyclovir Incidence of postherpetic pain

Brivudin compared to famciclovir

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

Author: Eric De Clercq

Email: tulkens@facm.ucl.ac.be

Home Page: http://www.md.ucl.ac.be/chaire-francqui/slides

Other information:
These slides are for information only. Do not make public use of them without the autorization of Prof. E. De Clercq and the organizers of the "Chaire Francqui". Please, adress your request to <tulkens@facm.ucl.ac.be>

Download presentation as PDF file